What is the iShares biotechnology ETF?

The iShares Biotechnology ETF ( IBB -0.74%) attempts to track the results of an index that includes all U.S.-listed stocks in the biotechnology sector. The ETF currently owns around 275 biotech stocks. Among the iShares Biotechnology ETF's top holdings are some of the biggest biotech stocks based on market capitalization rank.

What is the best biotech ETF?

The ETF provides diversified exposure across large, mid, and small-cap stocks within the biotechnology sector. It is one of the best biotech ETFs. As of April 1, 2024, SPDR S&P Biotech ETF (NYSE:XBI) held $7,492.98 million in assets under management, and featured a gross expense ratio of 0.35%. Its portfolio consists of 133 stocks.

What is a biotech ETF?

Biotech ETFs have all the characteristics of ETFs in general. The key difference is that these ETFs hold only the stocks of companies that focus on biotechnology. The best biotech ETFs tend to be the biggest ones. They have large amounts of assets under management and relatively low expense ratios. Here are five of the best biotech ETFs.